Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development of a rapid method to generate multiple oncolytic HSV vectors and their in vivo evaluation using syngeneic mouse tumor models

10 Jan 2006

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Herpesvirus Infections and Treatments
Share to Viral Infectious Diseases and Gene Expression in Insects
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 16421599
DOI: 10.1038/sj.gt.3302717

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of a rapid method to generate multiple oncolytic HSV vectors and their in vivo evaluation using syngeneic mouse tumor modelsPMID 16421599Read ↗

A novel oncolytic HSV-1 vector for cancer immunotherapySemantic proximity Read ↗

Viral oncolysis by herpes simplex virus and other viruses.Semantic proximity Read ↗

Developing oncolytic viruses for clinical use: A consortium approachSemantic proximity Read ↗

Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applicationsSemantic proximity Read ↗

A novel oncolytic virus engineered with PD-L1 scFv effectively inhibits tumor growth in a mouse modelSemantic proximity Read ↗

Oncolytic herpes simplex virus vectors for cancer virotherapy.Semantic proximity Read ↗

Feasibility of herpes simplex virus type 1 mutants labeled with radionuclides for tumor treatment.Semantic proximity Read ↗

Oncolytic virus therapy using genetically engineered herpes simplex viruses.Semantic proximity Read ↗

Replicative oncolytic herpes simplex viruses in combination cancer therapies.Semantic proximity Read ↗

Designing herpes viruses as oncolyticsSemantic proximity Read ↗

Tumor Tropism of DNA Viruses for Oncolytic VirotherapySemantic proximity Read ↗

Cellular genetic tools to control oncolytic adenoviruses for virotherapy of cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.